ASLAN Pharmaceuticals Competitors and Similar CompaniesClear all

ASLAN Pharmaceuticals's competitors and similar companies include Telix Pharmaceuticals, NiKang Therapeutics and Oricell Therapeutics.

	ASLAN Pharmaceuticals ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for the global healthcare market.	Telix Pharmaceuticals Telix Pharmaceuticals is a company developing molecularly targeted radiation products for cancer care.	NiKang Therapeutics NiKang Therapeutics is a biotech company focused on developing small molecule oncology medicines.	Oricell Therapeutics OriCell Therapeutics (原启生物科技（上海）有限责任公司) is a biotech company specializing in tumor immunotherapy drug development.
Founding Date	Founding Date N/A	Founding Date 2015	Founding Date 2017	Founding Date 2015
Type	Type Private	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma
Locations	Locations SG HQ Collingwood, AU	Locations North Melbourne, AU HQ Milton, AU Sydney, AU Herstal, BE Burnaby, CA Kyoto, JP Lancy, CH see more	Locations Wilmington, US HQ	Locations Shanghai, CN HQ
Employees	Employees 35	Employees 415	Employees 403% increase	Employees 235% increase
Financial
Revenue (est.)	Revenue (est.) $12m (FY, 2023)	Revenue (est.) $803.8m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $356m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $12m (FY, 2023)	Gross profit $449m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income ($44.2m) (FY, 2023)	Net income ($7.1m) (FY, 2025)	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round $ 23m (almost 10 years ago)	Latest funding round N/A	Latest funding round $ 200m (almost 5 years ago)	Latest funding round $ 120m (almost 4 years ago)
Total funding raised	Total funding raised $ 100m	Total funding raised N/A	Total funding raised $ 200m	Total funding raised $ 162m